Catherine Ma

Researcher

University of Arkansas for Medical Sciences

unknown

1 h-index 6 pubs 2 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Catherine Ma's research focuses on understanding the progression of monoclonal gammopathy of undetermined significance (MGUS) to multiple myeloma. Her work investigates predictive indicators for this transition, including the identification of specific molecular subtypes of MGUS that exhibit resistance to progression, such as the Low-Bone (LB) subtype.

Her recent publications also address risk factors for multiple myeloma progression, with a particular emphasis on African American patients. This includes identifying that the LB subtype of multiple myeloma is associated with inferior outcomes in this demographic. Ma is a Co-Principal Investigator on a grant from the NIH/National Institute on Minority Health and Health Disparities, totaling $4,749,323, which supports research related to health disparities and societal well-being.

Metrics

  • h-index: 1
  • Publications: 6
  • Citations: 2

Selected Publications

  • Polyclonal plasma cell (PolyPC) signature as a key indicator for predicting the progression of MGUS to multiple myeloma (2025) DOI
  • Identification of Risk Factors for Myeloma Progression in African American Patients (2024) DOI
  • The Low-Bone (LB) Subtype of Multiple Myeloma Exhibits an Inferior Outcome in African Americans (2024) DOI
  • Of Seven Molecular Subtypes in MGUS the Low Bone Disease (LB) Subtype Exhibits Resistance to Multiple Myeloma Progression (2024) DOI

Federal Grants 1 $4,749,323 total

NIH/National Institute on Minority Health and Health Disparities Co-PI Sep 2021 - Jun 2026

Center for Research, Health and Society

National Institute on Minority Health and Health Disparities $4,749,323 P50

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics